TP53 and head and neck squamous cell carcinoma: Three therapeutic strategies are proposed for the restoration of p53 function and consequently for the improvement of therapeutic results in HNSCC: targeting the degradation or direct inhibition of wild-type p53 (WT), reactivation of transcriptional activity by binding mutant p53 and restoration of WT p53 status [2,3,4].